Sep. 7 – A few China and EU countries investment deals have been made meaningful at the end of August and beginning of September, 2015, there are other updated China investment deals in August. Here are the newly key China invest in Europe deserve to be noticed below:
Changyu Pioneer Wine to acquire 75% stake in Spain’s Dicot Partners – Yantai Changyu Pioneer Wine Company Limited announced on August 28 that it has invested EUR 26.25m for a 75% stake in Spanish wine producer Dicot Partners, S.L (DP Group) from Comercial Gatar, S.L (CG) and Gestion Ganuza, S.L. (GG).
Founded in 2002, DP Group has been producing and distributing wine from Spain’s Rioja region for thirteen years. CG and GG are both Spanish wine consulting service providers each holding 49.9997% equities of DP prior to the transaction. In this transaction, Changyu Pioneer expects to capitalize on the popularity of DP Group’s high quality, low cost wine products to bolster growth.
HNA to purchase Thomson Reuters’London office – HNA Investment Holdings signed a deal on August 28 for the purchase of Thomson Reuters’ London office for an undisclosed amount. The office building, located at 30 South Colonnade, is one of the iconic London buildings at Canary Wharf, adjacent to other well-known investment organizations such as CITI Bank, HSBC, Northern Trust and Morgan Stanley.
HNA Investment Holdings, a wholly-owned subsidiary of Hainan Airlines Group, is growing into a diversified investment and financing platform for its parent company. HNA group is a multinational conglomerate encompassing aviation, financial services, real estate, tourism, and logistics. The Group manages an asset base of approximately RMB 500bn, and operates 10 companies listed in mainland stock exchanges and more than 30 companies overseas.
This acquisition is HNA’s first material purchase in London. It lays the foundation for its expansion in Europe and will further enhance its international reputation. Since April 2015, HNA has accelerated its overseas expansion. The Group acquired a 6.2% stake in South African Comair Limited for RMB 78.13m in May, and then bought 2.99 million common shares of the well-known Red Lion Hotel in June. Later in July it purchased a stake in the Irish airplane leasing company Avolon for RMB 2.62bn, and purchased full control of the airport luggage handler Swissport International Ltd .for RMB 17.5bn.
China Huaxin and Nokia to set up joint venture – China Huaxin Post and Telecommunication Economy Development Center (China Huaxin) signed a Memorandum of Understanding (MoU) on August 28 with Nokia, the well-known North European telecommunications equipment maker, confirming their intent to combine Nokia’s telecommunications infrastructure businesses in China and Alcatel-Lucent Shanghai Bell into a new joint venture. The new joint venture will operate under the name of Nokia Shanghai Bell and will be registered in the Shanghai Free Trade Area. As agreed under the MoU, Nokia will hold 50% plus one share in the new joint venture, while China Huaxin will hold the remaining shares.
Founded in 1993, China Huaxin is an industrial investment company seeking overseas opportunities in the Information and Communications Technologies sector. The Company co-founded Alcatel Shanghai Bell in 1984, with joint capital contributions from Alcatel-Lucent (China) Investment Co., Ltd., Lucent Technologies Investment Co., Ltd. and Alcatel Participations Chine. The new joint venture is conditional upon Nokia’s planned merger with Alcatel-Lucent in the first half of 2016. Until the merger is complete, Nokia and Shanghai Bell will continue to operate as two independent entities.
China’s Boai NKY Pharmaceuticals to acquire shares in Sweden’s NeoDynamics – Boai NKY Pharmaceuticals Ltd. (NKY) announced on August 31 that it will acquire an SEK 30m share in Sweden’s NeoDynamics AB. This investment will be paid in two equal installments, with the first installment of SEK 15m to be paid by October 31 while second installment will be conditional upon a number of precedents.
NeoDynamics AB is a Swedish company dedicated to developing high-precision solutions for early cancer detection and treatment, and is expected to pass the European Union CE certification in 2016. The company is currently raising funds for its NeoNavia systems. NKY is the largest Chinese polyvinyl-pyrrolidone (PVP) producer. The company owns two invention patents, six utility model patents, and 11 proprietary technologies. It views this investment as a step towards broadening its business scope and boosting profitability.
Huadong Medicine to acquire 100% interest in Kremers Urban – Huadong Medicine Co., Ltd. announced on August 29 that it intends to bid for a 100% interest in Kremers Urban Pharmaceuticals Inc, the wholly-owned U.S. subsidiary of Belgium-based UCB S.A.
Kremers Urban is a generic drug manufacturer in the U.S. which specializes in extended-release tablets. Founded in 1993, Huadong Medicine is a listed pharmaceutical company focused on pharmaceutical R&D, manufacturing, and distribution. The company expects to create substantial commercial value by introducing Kremers Urban’s medical products in China.